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Abstract
Background: Mobile health (mHealth) has continuously been used as a method in behavioral research to improve
self-management in patients with chronic diseases. However, the evidence of its effectiveness in chronic disease
management in the adult population is still lacking. We conducted a systematic review to examine the effectiveness of
mHealth interventions on process measures as well as health outcomes in randomized controlled trials (RCTs) to
improve chronic disease management.
Methods: Relevant randomized controlled studies that were published between January 2005 and March 2016 were
searched in six databases: PubMed, CINAHL, EMBASE, the Cochrane Library, PsycINFO, and Web of Science.
The inclusion criteria were RCTs that conducted an intervention using mobile devices such as smartphones
or tablets for adult patients with chronic diseases to examine disease management or health promotion.
Results: Of the 12 RCTs reviewed, 10 of the mHealth interventions demonstrated statistically significant improvement in
some health outcomes. The most common features of mHealth systems used in the reviewed RCTs were real-time or
regular basis symptom assessments, pre-programed reminders, or feedbacks tailored specifically to the data provided by
participants via mHealth devices. Most studies developed their own mHealth systems including mobile apps. Training of
mHealth systems was provided to participants in person or through paper-based instructions. None of the studies
reported the relationship between health outcomes and patient engagement levels on the mHealth system.
Conclusions: Findings from mHealth intervention studies for chronic disease management have shown promising
aspects, particularly in improving self-management and some health outcomes.
Keywords: Mobile applications, Disease management, Mobile health, Chronic disease management, Self-management
Background
The prevalence of chronic diseases, such as cancer, car-
diovascular diseases, chronic pain, diabetes, and respira-
tory diseases is continuously increasing with regard to
an aging society worldwide. According to the World
Health Organization, chronic diseases are the leading
cause of mortality in the world, accounting for more
than 60% of all deaths [1]. Chronic disease is, therefore,
a global burden. For example, according to the report by
the Centers for Disease Control and Prevention (CDC)
in the United States (US), about half of all American
adults, approximately 117 million people, have one or
more chronic disease conditions including heart disease,
stroke, cancer, type 2 diabetes, obesity, or arthritis [2].
One in four adults in the US had two or more chronic
diseases in 2012 [2]. Chronic diseases are the main cause
of death among Americans, with 48% dying from cancer
or heart diseases in 2010 [3]. In 2010, about 86% of
Americans’ health care expenditure was for chronic dis-
ease treatment [4]. Therefore, chronic disease manage-
ment is now a major public health issue in the US.
Likewise, managing chronic diseases is also a challenge
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in other countries [5, 6]. For instance, over 40% of the
population aged 15 years or older had a chronic disease
condition in the European Union countries [5] and
chronic diseases accounted for a substantial proportion
of deaths throughout Southeast Asia [6].
With advances in mobile technologies, approaches
based on mobile health (mHealth)—defined as “an
area of electronic health (eHealth) with the provision
of health services and information via mobile tech-
nologies such as mobile phones and Personal Digital
Assistants (PDAs)” [7]—have been very popular in
health care and public health [8–11]. Current evi-
dence shows that the advantages of using mHealth
devices are not only for the improvement of diagnosis
and treatment but also the social connection with
people [12]. Behavioral interventions using mobile ap-
plications (apps) on smartphones or tablet computers
in enhancing self-management for patients with
chronic diseases, such as heart failure [13] or diabetes
[14], have been studied [9, 12]. For instance, a food
intake diary, physical activity monitoring, and home
blood sugar monitoring via mHealth systems are
commonly used for diabetes management [14–16]
while monitoring of weight, symptoms, and physical
activity are common features of heart failure interven-
tions [13, 17].
However, the evidence from current literature using
the mHealth approach on improving health outcomes is
inconsistent; some studies have shown that mHealth-
based behavioral interventions are potentially effective in
chronic disease management, whereas other studies did
not obtain supportive results [9]. Previously, the evalu-
ation of mHealth-based research focused on feasibility
and acceptability of mHealth tools.
Rather than relying on feasibility research, which often
does not utilize randomization in their intervention and/
or a control group, and often lacks an effective size, a
number of systematic or integrated reviews examined
randomized controlled trials (RCTs) in diabetes manage-
ment. These studies have demonstrated positive physio-
logical and behavioral outcomes as well as incentive
driven outcomes with mHealth systems [14–17]. How-
ever, there is limited literature showing that mHealth ap-
proaches can be useful for the self-management in
patients with other chronic diseases. Therefore, an in-
depth evaluation of RCTs on interventions that employ
mHealth technologies and participants’ adherence to the
interventions, training methods, intervention dosage,
and length of follow-ups as outcomes of interest should
be performed to provide recommendations on what fac-
tors make mHealth interventions effective for chronic
disease management.
Thus, the purpose of this study was to perform a sys-
tematic review of RCTs using mHealth interventions for
chronic disease management in adult populations to
examine the effectiveness of mHealth interventions on
health outcomes and process measures.
Methods
The Preferred Reporting Items for Systematic Review
and Meta-Analysis (PRISMA) guidelines [18] were used
in this systematic review. The PICOS (participants, in-
terventions, comparisons, outcomes, and study design)
approach was used to develop a research question to
guide the search strategies and review: that is, do inter-
ventions using mobile health applications improve health
outcomes and process measures for adults with chronic
diseases in RCTs?
Search strategies
Searches were performed to retrieve studies that were
published in peer-reviewed journals from January 2005
to March 2016, and written in English; the following da-
tabases were used: PubMed, CINAHL, EMBASE, the
Cochrane Library, PsycINFO, and Web of Science. We
used combinations of the key words and indexing terms
such as MeSH or Emtree linked to the search domains.
An example of a PubMed search strategy is as follows:
for mobile interventions, “Mobile Applications”[Mesh]
OR “Cell Phones”[Mesh] OR “Computers, Handheld”[-
Mesh] OR “mobile health” OR “m-health” OR mhealth
OR “mobile-health” OR smartphone* OR “smart-phone*”
OR “mobile phone*” OR “mobile-phone*” OR “cellular
phone*” OR “cellular-phone*” OR “smart device*” OR
“smart-device*” OR “tablet* PC*” OR “tablet-based” OR
“tablet* device*”; for chronic disease outcomes, “Disease
Management”[Mesh] OR “Chronic Disease/prevention
and control”[Mesh] OR “Chronic Disease/therapy”[Mesh]
OR “disease* manag*” OR “disease* monitor*” OR moni-
tor* OR “health promot*” OR Promot*, and for method,
“Randomized Controlled Trial” [Publication Type] OR
“Randomized Controlled Trials as Topic”[Mesh] OR
“Controlled Clinical Trial”[Publication Type] OR rando-
mized[Title/Abstract] OR randomised[Title/Abstract] OR
randomly[Title/Abstract] OR “random* assign*”[Title/Ab-
stract] OR trial*[Title/Abstract]. Then, those three
groups of search results were combined with “AND” (see
Additional file 1 for search strategy for each database).
Study selection
The inclusion criteria were as follows: adult patients
with chronic diseases (except diabetes) as the target
population, an intervention that involved using a mobile
application for smartphones or tablets, and assessing the
health outcomes and process measures. The exclusion
criteria were as follows: studies that focused on a healthy
population, pregnant women, non-adults (i.e., adoles-
cents and children), or healthcare providers (e.g., apps
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for physicians’ or nurses’ use only); studies that used
only qualitative methods (e.g., focus groups or group/in-
dividual interviews) or simple usability tests; and studies
that measured psychological outcomes only (Table 1).
Two reviewers (MC and SAL) independently screened
titles, abstracts, and full-text articles to decide whether
an article was relevant to the review. In case of disagree-
ment, a third person was consulted (JL). We excluded
studies of diabetes management because several system-
atic reviews and integrated reviews have already been
published to report the effectiveness of mHealth-based
interventions [14–17]. Only studies published in peer-
reviewed journals were included.
Data extraction
Data were extracted from the selected articles and en-
tered into an electronic data sheet. The contents of the
data sheet included year of publication, research ques-
tion or purpose, study design, types of disease, types of
outcome and measurement, and the main results. In in-
stances of disagreement, each case was discussed by the
authors.
Assessment of risk of bias
Selection bias (random sequence generation and alloca-
tion concealment), performance bias (blinding of partici-
pants and personnel), detection bias (blinding of
outcome assessment), attrition bias (incomplete out-
come data), reporting bias (selective reporting), and
other biases (determined according to sample size calcu-
lation method, inclusion/exclusion criteria for patients’
recruitment, comparability of baseline data, funding
sources, and any other potential methodological flaw
that might have influenced the overall assessment) were
assessed with the tool for risk of bias given in the
Cochrane Handbook for Systematic Reviews of Interven-
tion [19]. For each risk of bias item, the studies were
classified as “unclear,” “low,” or “high” risk of bias re-
spectively. Two reviewers (MC and SAL) assessed the
trials independently and disagreements between two au-
thors were resolved via discussion.
Operational definitions of the terms used in this review
Studies on feasibility assess whether or not an interven-
tion is appropriate for further testing, whereas studies
on acceptability (which is a component of feasibility) de-
termine how recipients react to that intervention [20].
Effectiveness is defined as an intervention study that
shows statistical differences of one or more outcomes of
interest measured between intervention and control
groups. Health outcomes included physiological out-
comes (e.g., gait and balance in patients with Parkinson’s
disease or fatigue in patients with cancer) and psycho-
logical outcomes (e.g., quality of life, depressive symp-
toms, anxiety). Process measures [21] included
participants’ adherence to, satisfaction with, and/or the
level of engagement with mHealth systems. These
process measures could be assessed via quantitative tools
such as surveys or qualitative methods such as open-
ended questions or a focus group interviews with inter-
vention participants.
Results
Figure 1 shows the PRISMA flow diagram indicating the
search process to select the final studies that met the in-
clusion criteria and thus were included in this systematic
review. A study conducted by Kristjánsdóttir et al. was
published as part 1 [22] and part 2 [23], which corre-
sponded to short-term and long-term follow-ups, re-
spectively. The results of both follow-ups were reviewed.
Accordingly, the results of this systematic review are
based on 12 studies from 13 published articles with
quantitative evaluations.
Table 2 presents the summary of 12 RCT studies
reviewed in this paper. The variety of chronic diseases
managed using mobile apps included allergic rhinitis
and asthma, cancer, cardiovascular diseases, chronic
pain, chronic kidney disease, lung transplantation, Par-
kinson’s disease (PD), and spinal bifida. Diabetes man-
agement using mHealth apps has been evaluated in
other literature and thus was not included. Among the
12 studies reviewed, 10 studies showed statistically sig-
nificant mHealth app intervention effects on some vari-
ables that were examined in each study, while two of the
12 studies reviewed showed no statistically significant
mHealth intervention effects on outcomes of interest
when comparing between treatment and control groups.
Two studies in this review were feasibility studies aimed
at testing mHealth interventions for chronic disease
management [24, 25] and one study was a pilot study
evaluating a smartphone-based symptom management
system for chemotherapy management [26]. These stud-
ies were also listed as RCTs.
Table 1 Inclusion and exclusion criteria
Inclusion
criteria
• studies that included adult patients with
chronic diseases (except diabetes) as the
target population
• studies that involved using a mobile application
• studies that focused on disease management
or health promotion
Exclusion
criteria
• studies that included healthy people, pregnant
women, non-adults (i.e., adolescents and children),
and healthcare providers
• studies that used only qualitative methods
or simple
usability tests
• studies that measured psychological
outcomes only
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Studies reporting significant effects on outcomes
The majority of mHealth RCT-studies in this systematic
review (10 out of 12 studies, 83.3%) showed statistically
significant effects on health outcomes by incorporating
mobile applications in managing chronic diseases. Those
studies demonstrated improved physical functioning, ad-
herence to prescribed medications, and/or ease of symp-
tom evaluation and reports to care providers, as well as
process measures including patient satisfaction with
mHealth management and feasibility of smart-phone-
based self-management interventions.
Kearney et al. [26] in the United Kingdom reported
significant improvement in fatigue (odds ratio, OR =
2.29; 95% CI, 1.04–5.05; P = 0.040) and hand-foot syn-
drome (OR control/intervention =0.39; 95% CI, 0.17–
0.92; P = 0.031) in patients with lung, breast, and colo-
rectal cancer using a mobile phone-based remote moni-
toring of chemotherapy-related symptoms in
comparison to the usual care group. In Norway, Krist-
jánsdóttir et al. [22, 23] showed a favorable effect on
pain management in a 4-week follow-up (catastrophizing
score lower for Intervention, M = 9.20, SD = 5.85, com-
pared to Control, M = 15.71, SD = 9.22, P < 0.01, with a
large effect size, Cohen’s d = 0.87) but not in the 5-
month and 11-month follow-ups (outcome variables
including catastrophizing, acceptance, functioning, and
symptom level, all P > 0.1). In Spain, Garcia-Palacios et
al. [27] developed an ecological momentary assessment
(EMA) for chronic pain in fibromyalgia patients and
found that patients with less familiarity with technology
using a mobile EMA system via their smartphones
showed higher levels of compliance than patients with a
paper-based diary (complete record t = − 4.446, d = 1.02,
reference Cohen’s d > =0.8, large effect). In Turkey, Cingi
et al. [28] reported that patients with allergic rhinitis or
asthma displayed better quality of life or well-controlled
asthma scores by using the mHealth intervention com-
pared to the control group (all P < 0.05). Dicianno et al.
[24] demonstrated the feasibility of a mHealth interven-
tion for patients with spina bifida to improve self-
management skills and high usage of the mobile system
was associated with positive changes in the self-
management skills. In Sweden, Hägglund et al. [29]
tested a tablet-based intervention in patients with heart
failure (HF) and found improved self-care and health-
related quality of life (HRQoL) and a reduction in HF-
related hospital days (risk ratio, RR = 0.38; 95% CI, 0.31–
0.46; P < 0.05). In Israel, Ginis et al. [25] conducted
home-based smartphone-delivery automated feedback
training for gait in people with PD, and found significant
Fig. 1 PRISMA flow diagram for the systematic review process. The step-by-step process of the application of inclusion and exclusion criteria
generated the final number of studies included in the systematic review. †Note: Kristjánsdóttir et al. (2013) was published as part 1 [22] and part 2
[23] with respect to a short-term follow-up and long-term follow-up; thus, the results are based on 12 studies from 13 published articles
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improvement in balance (F(2,108) = 3.73, P = 0.04) from
baseline to post-test.
Martin et al. [30] in the US found that an automated
text message system increased physical activity to pre-
vent cardiovascular diseases in phase 1 (weeks 2 to 3)
and phase 2 (weeks 4 to 5), all P < 0.001. Piette et al. [31]
in the US reported that the intervention group involving
“CarePartners” connecting to a relative or friend living
outside their home showed improvement in medication
adherence and caregiver communication (all P < 0.05).
DeVito Dabbs et al. [32] in the US conducted an RCT
for patients with lung transplantation and reported im-
provement in self-monitoring (OR = 5.11; 95% CI, 2.95–
8.87; P < 0.001), adherence to medical regimen (OR
=1.64; 95% CI, 1.01–2.66, P = 0.046), and reported ab-
normal health indicators more frequently (OR = 8.9; 95%
CI, 3.60–21.99; P < 0.001).
Studies reporting similar or no effects on outcomes
Two of the twelve studies reviewed (16.7%) showed simi-
lar or no effects of mHealth-based interventions on
main outcomes of interest compared to control groups.
In Finland, Vuorinen et al. [33] found no difference in
the number of HF-related hospital days (incidence rate
ratio, IRR = 0.812, P = 0.351). However, patients in the
telemonitoring intervention group used more healthcare
resources; increased number of visits to the nurse (IRR
= 1.73; 95% CI, 1.38–2.15; P < 0.001), more time spent
with nurses (mean difference = 48.7 min, P < 0.001), and
increased number of telephone contacts initiated by
nurses (IRR = 5.6; 95% CI, 3.41–7.63; P < 0.001). In
Spain, Cubo et al. [34] reported a trend of lower PD
functional status (the Unified Parkinson’s Disease Rating
Scale, UPDRS I) in patients on home-based monitoring
compared to patients in standard in-office visits (P =
0.06), while other outcomes (measured by UPDRS II, III,
IV subscales) and HRQoL in PD did not show statisti-
cally significant differences between the intervention and
control groups. Cubo et al. [34], however, explained that
the approach of using home-based motor monitoring via
mHealth applications compared to standard office visits
in the 1-year follow up was cost-effective (incremental
cost-effectiveness ratio, ICER, per unit of UPDRS sub-
scales ranging from €126.72 to € 701.31).
mHealth interventions
Table 3 presents the details of mHealth interventions
including duration, mobile app type, app content, and
training methods. A quarter of the studies (3 out of
12) reported the feasibility of the mHealth interven-
tion as a pilot study to assess the potential for suc-
cessful implementation of the mHealth intervention
to patients/participants [24–26]. The majority of stud-
ies used smartphones as a mobile device, two studies
[29, 34] used tablets for mHealth interventions, and
two studies used telemonitoring wireless devices in-
cluding weight scales for patients with HF [29] or gait
detectors for patients with PD [25]. The length of in-
terventions ranged from two weeks to twelve months;
half of the studies (6/12, 50%) had more than six-
month intervention periods and follow-ups. Most
common components of mHealth interventions in-
cluded remote symptom monitoring and self-
assessment as well as tailored automated messages or
self-care education to coach patients with chronic dis-
ease conditions that needed active disease manage-
ment. One particular study by Kearney et al. was
more inclusive in that it provided real-time feedback
and tailored such feedback for symptom management
depending on the severity, offering pharmacological,
nutritional, or behavioral advice when needed [26].
The sample size of the studies reviewed was be-
tween 28 (patients with spina bifida) and 372 (pa-
tients with heart failure). In terms of subjects,
studies included patients who were 18 years and
above, with some studies limited to a particular age
range such as 18–40 [24] or up to 69 years [30]. The
mean age of participants in the mHealth intervention
studies ranged from 30-year-old patients with spina
bifida [24] to 75-year-old patients with HF [29]; the
approximate average age group in this 12-study re-
view was in the 50s. None of the studies reported ef-
fectiveness of mHealth intervention by age
categories. These 12 studies also did not report par-
ticipants’ prior experience with mobile devices such
as smartphones or educational background, which
may have affected the ability to use mHealth apps
via mobile devices. Outcomes of interventions were
measured either by mHealth systems directly or by
paper-based questionnaires.
In terms of mHealth intervention training, either
face-to-face information sessions at baseline or paper-
based instructions were used in most studies. Kearney
et al. [26] found that symptoms were reported
differently on a paper-based questionnaire and mobile
phone. Participants in the mobile group reported
lower levels of fatigue compared to those in the
paper-based group (OR non-mobile/mobile = 2.29, 95% CI
1.04–5.05, P = 0.04) [26]. Reporting cancer toxicity
symptoms (e.g., hand-foot syndrome and mucositis)
in real time might allow for more accurate measure-
ment [26].
None of the studies reported process measures, in-
cluding adherence, level of engagement, and/or satisfac-
tion with the mHealth systems. Potentially, there was
limited information on such measures in the published
articles with the authors possibly publishing the process
measures elsewhere.
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Risk of bias assessment
The risk of bias in the reviewed studies is summarized
in Fig. 2 and shown for individual studies in Fig. 3. The
intervention studies generally performed well in their
risk of bias for random sequence generation (62% low
risk), allocation concealment (23% low risk), blinding of
participants and personnel (8% low risk), blinding of
outcome assessors (15% low risk), incomplete outcome
data (69% low risk), and selective reporting (92% low
risk) (Fig. 2).
Considering the method of randomization, 5 trials did
not present details of randomization [25, 27, 29, 30, 33].
Only 2 studies reported use of an adequate allocation
concealment method [22, 32]. Although due to the na-
ture of the mHealth intervention, it is almost impossible
to blind participants and healthcare providers, one study
described the blinding of participants by providing the
same mobile phone application to both experimental
and control groups with different functionalities. The ex-
perimental group was given communication, health sta-
tus, or medication usage tracking, and a survey
questionnaire, whereas the control group received only
the survey questionnaire [28]. Only two trials were iden-
tified as blinding the outcome assessors. Four trials
failed to provide a full description of participants and
losses to follow-up during their trials [24, 28, 29, 31]. All
studies had a low risk for reporting bias. Devito et al.
had low risk for all items except blinding of participants
and personnel [32]. Hägglund et al. had low risk only for
reporting bias [29] (Fig. 3).
Discussion
This systematic review has found a potential favorable
effect of mHealth interventions on health outcomes and
process measures in patients with chronic diseases in-
cluding asthma, cancer, cardiovascular diseases, chronic
pain, spina bifida, or Parkinson’s disease. The results
from the reviewed RCTs showed improvement in some
health outcomes in patients in managing their chronic
disease.
There were some commonalities and differences in
using mHealth in the reviewed studies. One of the com-
mon features useful in mHealth interventions is pre-set
and tailored feedback on reported symptoms. The mo-
bile application systems used in the reviewed studies
were developed by the study team and validated and
refined in the previous studies that were conducted
before the RCTs. None of the commercial health apps
were used in the reviewed studies. Most studies utilized
research staff to provide training in mHealth systems
for the participants via face-to-face or information
group sessions, or through information materials, while
one study [26] used local nurses to train patients. None
of the reviewed studies addressed whether their
mHealth systems were incorporated into daily medical
practice in either clinic settings or acute care hospitals,
meaning that there were no signs of their implementa-
tion in real health care systems. Challenges in real-life
settings may relate to lack of financial incentives for
providers in using mHealth tools or uncertainty regard-
ing privacy and security of information transferred via
mHealth systems [35].
Interventions to promote self-management in
patients with chronic diseases started from web-based
and/or telephone-based interventions to mHealth-
based interventions. Unlike those previous behavioral
interventions limited to places where patients with
chronic diseases had access to the treatment advice,
mHealth interventions have advanced features such as
real-time symptom monitoring and feedback [25, 34,
36]. For example, patients with PD receive real-time
feedback on their selected gait parameters during
their walks via the preset gait app developed from
evidence-based exercise guidelines [25]. This is an
example of how using well-designed and validated
mHealth apps in daily life can benefit health
outcomes.
Fig. 2 Risk of bias assessment: Summary graph
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The number of smartphone users has shown great in-
creases; in the US [37] it is estimated to reach 224.3 mil-
lion in 2017, up from 171 million in 2014; worldwide it
was [38] 2.32 billion in 2017, up from 1.57 billion in
2014. Approximately 77% of people in the US owned
smartphones in 2016 [39]. Using mobile devices for
mHealth is essential nowadays and approaches of
mHealth vary from sending text messaging for medical
appointment reminders to monitoring and assessing
symptoms in real-time, virtually at any location via wire-
less networks. Interventions using mHealth have also
eased medical coaching for caregivers as care partners
with healthcare professionals for effective chronic
disease management. Piette et al. [31] studied the com-
parative effectiveness of mHealth interventions support-
ing HF patients and their family caregivers and showed
improvement for medication adherence and caregiver
communication. The impact of including caregivers as a
part of mHealth users—one of the care supporting
groups—on actual patients’ health outcomes should con-
tinue to be studied in the context of an increasing aging
society.
Moreover, long-term follow-ups of responses from pa-
tients and caregivers who have used mHealth need to be
evaluated. Areas that need to be studied include the
optimum length of time and frequency of the mHealth
delivery system as well as type of technology and train-
ing. For example, effective frequencies of automated re-
minders or coaching messages, when additional
reminders should be sent, and when people become
tired or irritated by automated messages need to be
studied. Users of mHealth might experience fatigue from
automated reminders and eventually mHealth interven-
tions could become ineffective. Other systematic reviews
on chronic disease management showed that the fre-
quency of input into mHealth systems was a burden on
participants and affected the attrition rate [17]. In this
review, the length of the intervention in the 12 studies
varied from 2 weeks to 12 months; 5 of 12 studies (about
42%) had less than 2-month interventions while 4 stud-
ies (about 33%) had 1 year of intervention. The positive
health outcomes of the various studies were not directly
related to the length of the intervention or training
methods of mHealth in the reviewed studies.
One aspect of mHealth approaches that also needs to
be considered is effective clinical communication be-
tween patients and healthcare professionals who need to
respond to patients’ questions via mHealth systems.
Cingi et al. [28] reported healthcare providers (i.e., resi-
dents) expressed an improvement in communication
with patients via mHealth; however, they found that
using mHealth tools as the primary method of commu-
nication was strongly opposed by the healthcare pro-
viders. Vuorinen et al. [33] also reported a significant
increase in the communication (i.e., telephone contacts)
between nurses and patients which in turn increased the
nurses’ workload during the trial. One recommendation
for reducing health care providers’ workload in mHealth
interventions is using advanced technology to respond
to patients’ questions regarding symptoms assessed and
reported via the mHealth systems.
While considering positive health outcomes (e.g., re-
duction of hospital readmission for HF-related condi-
tions or medication adherence) of patients with chronic
diseases, burden of healthcare professionals should be
measured as an outcome of mHealth interventions. An
adequate triage system can decrease healthcare
Fig. 3 Risk of bias assessment for individual studies. Low risk of
bias; Unclear; High risk of bias
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professionals’ response time for emergency needs re-
ported by mHealth users [28].
Common recommendations discussed in the studies of
this systematic review to improve mHealth interventions
include a simple and user-friendly-designed mHealth
system, data confidentiality, lay language use for struc-
tured and automated feedback or advice, positive motiv-
ation and improving engagement [28], and inclusion of
patient’s social supporters, such as family members,
friends, and/or peers [31].
There are several limitations in this systematic review.
First, we only selected randomized controlled trials for
this review and most of them were funded studies.
Therefore, the mHealth systems or smartphone apps
used in the studies were validated and relatively reliable
compared to health apps commercially available on the
market. Literature from studies on smartphone-based in-
terventions for chronic disease management that were
small scale with or without control group and/or had a
short-term follow-up has shown ambivalent results.
Thus, we intended to choose robust studies that used
randomization, control groups, and relevant follow-ups
for outcomes. We looked at the outcome changes at dif-
ferent follow-up points.
Second, we did not include mHealth intervention
studies for diabetes management since there is ample lit-
erature on diabetes management using mobile technol-
ogy approaches [14–17]. Third, we excluded studies
wherein health apps were used only by health profes-
sionals such as physicians or specialized clinical nurses.
We focused on patient-centered health apps as a part of
mHealth interventions in the review. Lastly, most of the
reviewed studies provided smartphones or tablets to par-
ticipating patients and thus, the results from this review
cannot yet be generalized among those who have finan-
cial concerns regarding purchasing mHealth tools. Al-
though the availability of wireless networks is increasing,
potential mHealth users such as patients with chronic
diseases or their caregivers may have limited data ser-
vices for their mobile devices due to financial concerns.
This might be an important issue during an emergency
when patients may have no access to evidence-based
medical advice via mHealth devices.
Conclusion
The findings from the majority of reviewed studies that
used mHealth interventions showed some health out-
come improvement in patients with chronic disease con-
ditions. Favorable factors in mHealth approaches are
automated text reminders, frequent and accurate symp-
tom monitoring (often in real time), and improved com-
munication between patients and healthcare providers
resulting in enhanced self-management in patients with
chronic conditions. Thus, the future of mHealth is
presumably optimistic. The relationship between engage-
ment of users on mHealth tools and outcome improve-
ment should be further studied. The studies reviewed in
this paper showed disease-specific mHealth interven-
tions that might be different from commercial mobile
health apps available to the public. Rigorously tested
mHealth apps developed through research should be
further considered to be made available to the general
population.
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